Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease.

Journal of Internal Medicine
Hannes HagströmMattias Ekstedt

Abstract

Nonalcoholic fatty liver disease (NAFLD) is defined by presence of steatosis in more than 5% of liver cells. The gold standard for diagnosis is liver biopsy, but this is seldom achieved due to costs and risk for side effects, and that is why the diagnosis is mostly made based on a combination of radiology and exclusion of other liver diseases. Disease severity staging can be noninvasively achieved with radiological exams such as elastography or blood-based markers that usually have lower sensitivity and specificity. NAFLD is today the most common chronic liver disease globally with a prevalence estimated to be 25%. Fortunately, for many persons NAFLD is an incidental finding with a good prognosis. Whilst a major focus has been on liver-related outcomes in NAFLD, there has recently been an increased interest in extrahepatic consequences of NAFLD. The most commonly studied outcomes include cardiovascular disease and cancer. The risk of adverse outcomes generally differs according to the baseline fibrosis stage. There is a five-time higher risk of liver-related events in NAFLD patients with fibrosis stage 3 as compared to those with no or little fibrosis. Meanwhile, the presence of nonalcoholic steatohepatitis (NASH) does not seem...Continue Reading

References

May 29, 1998·Circulation·P W WilsonW B Kannel
May 8, 2004·Gastroenterology·Naga ChalasaniStephen D Hall
May 17, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giorgio BedogniStefano Bellentani
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mattias EkstedtStergios Kechagias
Dec 17, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Cecilia SöderbergRolf Hultcrantz
Feb 16, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kohichiroh YasuiUNKNOWN Japan NASH Study Group, Ministry of Health, Labour, and Welfare of Japan
Mar 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvia Sookoian, Carlos J Pirola
Jun 18, 2011·Journal of Gastroenterology and Hepatology·Young In LeeHye Soon Park
Dec 20, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yasuji AraseTetsuro Kobayashi
Jan 25, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donghee KimW Ray Kim
Feb 4, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Sombat TreeprasertsukPaul Angulo
Jan 29, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Edith M KoehlerHarry L A Janssen
Feb 13, 2013·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K-W HuangF-Y Chang
Feb 1, 2014·Endocrine-related Cancer·Won-Mook ChoiHyo-Suk Lee
Apr 16, 2014·The Lancet. Diabetes & Endocrinology·Hannele Yki-Järvinen
Jun 24, 2014·Lipids in Health and Disease·Kathleen E CoreyRonald M Krauss
Sep 25, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paola DongiovanniLuca Valenti
Oct 15, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mohamed S SiddiquiArun J Sanyal
Jul 7, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Jin-Ho ParkSek Won Kong
Aug 1, 2015·Journal of Clinical Lipidology·Alper SonmezManfredi Rizzo
Aug 15, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiSharon Hunt
Sep 4, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Carlos J Pirola, Silvia Sookoian
Nov 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fabio PiscagliaUNKNOWN HCC-NAFLD Italian Study Group
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Jan 30, 2016·Metabolism: Clinical and Experimental·Elena BuzzettiEmmanuel A Tsochatzis
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
Apr 20, 2016·Journal of Hepatology·Sven M FrancqueWilhelmus J Kwanten
May 24, 2016·Journal of Hepatology·Giovanni TargherCorrado Barbui
Oct 22, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiRachel Beckerman
Aug 23, 2016·Digestive Diseases·Abdo Mahli, Claus Hellerbrand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Journal of Clinical and Translational Hepatology
Ramesh KumarUtpal Anand
Current Opinion in Cardiology
Lokpal S BhatiaChristopher D Byrne
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Philipp KasperHans-Michael Steffen
© 2021 Meta ULC. All rights reserved